Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James P Allison

Showing results (81-90 of 206) with videos related to

Pageof 21
Sort By:
Blood|June 5, 2008
CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashionBrian Kavanagh, Shaun O'Brien, David Lee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2005
Regulated costimulation in the thymus is critical for T cell development: dysregulated CD28 costimulation can bypass the pre-TCR checkpointJoy A Williams, Karen S Hathcock, David Klug, et al.
Cell Reports|September 29, 2015
Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent MannerRikke B Holmgaard, Dmitriy Zamarin, Yanyun Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2015
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV+ tumors when combined with an E6/E7 peptide vaccineTodd Bartkowiak, Shailbala Singh, Guojun Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 9, 2025
Anti-CTLA-4 generates greater memory response than anti-PD-1 via TCF-1Stephen Mok, Huey Liu, Didem Ağaç Çobanoğlu, et al.
Nature|December 31, 2005
Restoring function in exhausted CD8 T cells during chronic viral infectionDaniel L Barber, E John Wherry, David Masopust, et al.
Nature Communications|February 15, 2017
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunityDmitriy Zamarin, Rikke B Holmgaard, Jacob Ricca, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 19, 2012
Cutting edge: chronic inflammatory liver disease in mice expressing a CD28-specific ligandEmily Corse, Rachel A Gottschalk, Joon Seok Park, et al.
The Journal of Experimental Medicine|April 3, 2013
Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of EomesoderminMichael A Curran, Theresa L Geiger, Welby Montalvo, et al.
Cancer Immunology Research|July 11, 2019
Immunologic Correlates of Pathologic Complete Response to Preoperative Immunotherapy in Hepatocellular CarcinomaAhmed Omar Kaseb, Luis Vence, Jorge Blando, et al.
Pageof 21

Showing results (81-90 of 206) with videos related to

Sort By:
Pageof 21
Blood|June 5, 2008
CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashionBrian Kavanagh, Shaun O'Brien, David Lee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2005
Regulated costimulation in the thymus is critical for T cell development: dysregulated CD28 costimulation can bypass the pre-TCR checkpointJoy A Williams, Karen S Hathcock, David Klug, et al.
Cell Reports|September 29, 2015
Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent MannerRikke B Holmgaard, Dmitriy Zamarin, Yanyun Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2015
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV+ tumors when combined with an E6/E7 peptide vaccineTodd Bartkowiak, Shailbala Singh, Guojun Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 9, 2025
Anti-CTLA-4 generates greater memory response than anti-PD-1 via TCF-1Stephen Mok, Huey Liu, Didem Ağaç Çobanoğlu, et al.
Nature|December 31, 2005
Restoring function in exhausted CD8 T cells during chronic viral infectionDaniel L Barber, E John Wherry, David Masopust, et al.
Nature Communications|February 15, 2017
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunityDmitriy Zamarin, Rikke B Holmgaard, Jacob Ricca, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 19, 2012
Cutting edge: chronic inflammatory liver disease in mice expressing a CD28-specific ligandEmily Corse, Rachel A Gottschalk, Joon Seok Park, et al.
The Journal of Experimental Medicine|April 3, 2013
Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of EomesoderminMichael A Curran, Theresa L Geiger, Welby Montalvo, et al.
Cancer Immunology Research|July 11, 2019
Immunologic Correlates of Pathologic Complete Response to Preoperative Immunotherapy in Hepatocellular CarcinomaAhmed Omar Kaseb, Luis Vence, Jorge Blando, et al.
Pageof 21